Physician profile
Eran Gwillim
NPI 1851787477
$12,527.23
in general payments reported to CMS, 2019-2025
18 companies · $35.83 in 2025
The $35.83 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.33 · 2020: $240 · 2021: $365 · 2022: $1,059 · 2023: $893 · 2024: $9,837 · 2025: $35.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,452 · Food and Beverage: $1,314.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,452.25 |
| Food and Beverage | $1,314.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $9,500.49 | 2023-2024 | Spevigo |
| Sun Pharmaceutical Industries INC. | $379.35 | 2022-2023 | Winlevi, Absorica Ld |
| Galderma Laboratories, L.P. | $326.50 | 2020-2024 | Aklief, Epsolay, Oracea |
| Genzyme Corporation | $314.41 | 2020-2023 | |
| Pfizer INC. | $289.13 | 2022-2024 | |
| Allergan, INC. | $259.83 | 2019-2022 | |
| Incyte Corporation | $251.30 | 2022-2024 | Opzelura |
| Abbvie INC. | $248.82 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $204.08 | 2022-2023 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $135.38 | 2021-2023 | Dupixent |
| Mallinckrodt Hospital Products INC. | $125.01 | 2021 | |
| Genentech USA, INC. | $124.20 | 2021 | |
| Ucb, INC. | $106.21 | 2022-2023 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $105.58 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $87.39 | 2021-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $28.52 | 2022 | |
| Kyowa Kirin, INC. | $22.82 | 2023 | Poteligeo |
| Verrica Pharmaceuticals INC. | $18.21 | 2025 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eran Gwillim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.